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ABSTRACT
Objective: This study was undertaken to know about the antibacterial and anticancer activity of synthesized zinc oxide (ZnO) nanoparticles (NPs).
Methods: The ZnO NPs and different concentration of Ce3+ (0.05M, 0.10M, and 0.15M)-doped ZnO NPs were synthesized by coprecipitation method. 
The synthesized nanoparticles were analyzed by X-ray diffraction (XRD) and HRSEM. The antibacterial studies were performed against a set of 
bacterial strains as Gram-positive bacteria (Streptococcus aureus and Streptococcus pneumonia) and Gram-negative (Escherichia coli, Pseudomonas 
aeruginosa, Proteus vulgaris, Klebsiella pneumonia, and Shigella dysenteriae) bacteria. The cytotoxic effect of ZnO and Ce-doped ZnO was analyzed in 
cultured (A549) human lung cancer cell line.
Result: The XRD studies showed the wurtzite structure of nanoparticles. HRSEM analysis showed the spherical shape of ZnO and Ce-doped ZnO. The 
Zn0.85Ce0.15O NPs possessed more antibacterial effect as compared to the other ZnO and Ce-doped ZnO NPs. The Zn0.90Ce0.10O NPs created the highest 
cytotoxicity activity. With respect to cell death, as low a concentration of 68±0.05 μg/ml of Zn0.90Ce0.10O NPs was good enough to cause loss of viability 
of 50% of the cell as compared to ZnO and Zn1-xCexO (x=0.05 and 0.15) NPs.
Conclusion: Results from this work concluded that Zn0.85Ce0.15O and Zn0.90Ce0.10O NPs possess antibacterial and anticancer activity, respectively.
Keywords: Zinc oxide nanoparticles, Coprecipitation method, Antibacterial activity and anticancer activity, Human lung cancer cell line.
INTRODUCTION
Zinc oxide nanoparticles (ZnO NPs) are well recognized as a biocompatible 
multifunctional material with exceptional semiconducting, optical, 
and piezoelectric properties [1]. These materials are used in different 
potential application such as light-emitting diodes, lasers, sensors, 
actuators, transducers, and nanogenerators [1-6]. ZnO is one of the 
important semiconductor materials for wide band gap 3.36 eV and 
large exciton binding energy 60 meV at room temperature. This makes 
us interesting for its electro-optical applications [7].
The metal oxide nanomaterials are attractive for use in biomedical 
applications. It has been proposed that the high surface area of metal 
oxide nanoparticles significantly enhances their ability to produce 
reactive oxygen species (ROS) [8,9]. Toxicity of ZnO NPs is reported 
due to the generation of intracellular ROS and dissolved Zn ions [10]. 
ROS is generated through various mechanisms such as illumination 
of nanomaterials by ultraviolet (UV) light, disturbance of intracellular 
metabolic activities, and antioxidant system, result in the generation of 
oxidative stress in the cells. ROS can damage DNA, cell membrane, and 
proteins which may lead to cell death [11,12].
To traverse new strategies to discuss and develop the next generation 
of drugs or agents to control bacterial infections and cytotoxic effects, 
the antibacterial and anticancer properties of ZnO and Ce-doped 




Zinc (II) nitrate hexahydrate (AR), cerium (III) nitrate hexahydrate (AR), 
and NaOH (AR) are used as precursor without further purification. The 
details of experimental procedure for the preparation of pure ZnO and 
Zn1-xCexO (x=0.05M, 0.10M, and 0.15M) samples have been reported in 
our previous paper [7].
Antibacterial activity
The antibacterial activity of ZnO and Ce-doped ZnO NPs was investigated 
by disc diffusion method against the test Gram-positive bacteria 
(Streptococcus aureus and Streptococcus pneumonia) and Gram-
negative bacteria (Escherichia coli, Pseudomonas aeruginosa, Proteus 
vulgaris, Klebsiella pneumonia, and Shigella dysenteriae) on Mueller-
Hinton agar (MHA), according to the Clinical and Laboratory Standards 
Institute [13]. The media plates (MHA) were streaked with bacteria 
2-3 times by rotating the plate at 60° angles for each streak to ensure 
the homogeneous distribution of the inoculums. After inoculation, discs 
(6 mm Hi-Media) loaded with 1mg of the test samples were placed on 
the bacteria-seeded disc plates using sterile forceps. The plates were 
then incubated at 37°C for a day. The inhibition zone around the disc 
was measured and recorded. Amoxicillin (Hi-Media) was used as the 
positive controls against Gram-positive bacteria and Gram-negative 
bacteria, respectively, to compare the efficacy of the test samples.
Cell culture
The A549 human lung cancer cell line was obtained from the National 
Center for Cell Science, Pune, India. The cells were cultured in DMEM 
high glucose medium (Sigma-Aldrich, USA), supplemented with 10% 
fetal bovine serum (Gibco), and 20 ml of penicillin/streptomycin as 
antibiotics (Gibco), in 96-well culture plates, at 37°C in a humidified 
atmosphere of 5% CO2 in a CO2 incubator (Thermo Scientific, USA). All 
experiments were performed using cells from passage 15 or less.
Cell viability assay
The ZnO and Ce-doped ZnO NPs were suspended in dimethyl 
sulfoxide (DMSO) to make stock solution. These stock solutions were 
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diluted separately with media to get various concentrations of the 
complex. Two hundred milliliters of these samples was added to wells 
containing 5×103 A549 cells per well. DMSO solution was used as the 
solvent control. After 24 hr, 20 µl of 3-(4, 5-di-methylthiazol-2-yl)-2, 
5-diphenyl-2H-tetrazolium bromide solution (5 mg/ml in phosphate-
buffered saline [PBS]) was added to each well, and the plate was 
covered with aluminum foil and incubated for 4 hr at 37°C [14]. The 
purple formazan outcome was disposed by adding 100 μl of DMSO to 
each well. The absorbance was recorded at 570 nm (measurement) 
and 630 nm (reference) using a 96-well plate reader (Bio-Rad, iMark, 
USA). Data were possessed for three replicates each and were used to 
calculate the respective mean. The percentage inhibition was calculated 
from the data using the formula:
=  
Mean OD of untreated cells (control) 
 Mean OD of treate d cells
Mean OD of untreated cells (control)
× ( )100
Acridine orange (AO) and ethidium bromide (EB) staining
Apoptotic morphology was investigated by AO/EB double-staining method 
as described by Spector et al. with some modifications [15]. Briefly, the 
cells are treated with IC50 concentration of ZnO and Ce-doped ZnO for a 
day. After incubation, the cells were harvested and washed with cold PBS. 
Cell pellets were diluted with PBS to a concentration of 5×105 cells/ml and 
mixed with 25 µl of AO/EB solution (3.8 µM of AO and 2.5 µM of EB in PBS) 
on clean microscope slide and immediately examined under fluorescent 
microscope (Carl Zeiss, Axioscope2plus) with UV filter (450-490 nm).
The X-ray diffraction (XRD) patterns were recorded using (PANalytical 
X’Pert Pro). The surface morphology was studied through FEI QUANTA 
250 scanning electron microscope (SEM).
RESULTS AND DISCUSSION
XRD studies
From Fig. 1, the XRD pattern confirmed the synthesis of ZnO and 
Ce-doped ZnO NPs is in hexagonal wurtzite structure. The Ce-doped 
ZnO NPs have no impurity peaks and are detected as Ce3+/Ce4+ ions with 
cerium oxide between CeO2 and Ce2O3. The lattice constant “a” and “c” 
values at 3.2521 Å and 5.2111 Å for pure ZnO NPs. The substitution of 
Ce3+ ion instead of Zn2+ ion at their lattice site increases. The changes 
in lattice parameter values are due to the broadness of ZnO lattice by 
the substitution of Ce3+ (1.02 Å) ion to Zn2+ (0.74 Å) sites, with a greater 
ionic radius compared to Zn2+ in their tetrahedral coordinates. The 
lattice constant “a” and “c” values are (3.2540 Å, 3.2539 Å, and 3.2543 
Å) and (5.2138 Å, 5.2150 Å, and 5.2113 Å) for Zn0.95Ce0.05O, Zn0.90Ce0.10O, 
and Zn0.85Ce0.15O NPs, respectively. The average crystalline size was 39, 
32, 30, and 27 nm for ZnO and Ce-doped ZnO NPs, respectively. The 
decrease in D is mainly because of the distortion in the host ZnO lattice 
by the foreign impurity, i.e., Ce3+ [7].
Field emission SEM analysis
Fig. 2 shows the HRSEM image of ZnO and Ce-doped ZnO NPs. The 
unadulterated ZnO NPs and Ce-doped ZnO NPs are found to be in 
spherical-shaped morphology. Different concentration of Ce-doped ZnO 
NPs agglomerates with each other due to the increasing nucleation of 
Ce3+ ions and subsequent growth of ZnO NPs [7].
Antibacterial activity
Antibacterial activity of (Zn) ZnO and Ce-doped ZnO as Ce1, Ce2, and 
Ce3 is investigated against Gram-positive bacteria (S. aureus and 
S. pneumonia) and Gram-negative bacteria (E. coli, P. aeruginosa, P. 
vulgaris, K. pneumonia, and S. dysenteriae) are studied by disc diffusion 
method as shown in Fig. 3. Fig. 4 communicates the area of zone 
inhibition, and the activity as antibacterial which surrounds each ZnO 
and Ce-doped ZnO NPs filled with test specimen.
The antibacterial efficacy of ZnO NPs is commonly influenced by ROS, 
which is mainly related to the size, larger surface area, an increase in 
Fig. 1: X-ray diffraction pattern of the pure zinc oxide, Zn0.95Ce0.05O, 
Zn0.90Ce0.10O, and Zn0.85Ce0.15O nanoparticles [7]
oxygen vacancies, the diffusion capacity of the reactant, and the release 
of Zn2+ [16].
From antibacterial activity, ZnO and Ce-doped ZnO NPs; Zn0.85Ce0.15O 
NPs possessed more antibacterial effect as compared to the other ZnO, 
Zn0.95Ce0.05O, and Zn0.90Ce0.10O NPs. Increasing the concentration of Ce3+ 
increases the zone of inhibition.
The smaller sized NPs indeed have higher activity as antibacterial  [17,18]. 
The XRD pattern shows the particles size of ZnO and Ce-doped ZnO NPs 
as 39, 32, 30, and 27 nm, respectively. Zn0.85Ce0.15O NPs particles’ size 
is lesser as compared to the other ZnO, Zn0.95Ce0.05O, and Zn0.90Ce0.10O 
Fig. 2: HRSEM images of the (a) zinc oxide, (b) Zn0.95Ce0.05O, 
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NPs [7]. The particle with a small size can easily penetrate into bacterial 
membranes due to their large interfacial area, thus enhancing their 
antibacterial efficiency.
From the photoluminescence spectra, wavelengths of the blue 
emissions values are at 440, 439, 439, and 446 nm for ZnO and Ce-
doped ZnO NPs. This illustrates the larger count defects such as 
zinc and oxygen vacancies in the Zn0.85Ce0.15O NPs. Thus, there are 
increased count of ROS as compared to ZnO and Zn1-XCexO (x=0.05 
and 0.10) NPs.
Anticancer properties
The cytotoxic effect of the ZnO and Zn1-xCexO (x=0.05, 0.10, and 0.15) 
NPs were examined in cultured (A549) human lung cancer cell line 
by exposing cells for 24 hr to culture medium containing unmixed 
ZnO, Zn0.95Ce0.05O, Zn0.90Ce0.10O, and Zn0.85Ce0.15O NPs at 280±0.05, 
82±0.05, 68±0.05, and 76±0.05 µg/ml for IC50 concentration as 
shown in Fig. 5a-d. In relation to cell death, a minimum concentration 
68±0.05 µg/ml for 24 hr treatment of Zn0.90Ce0.10O NPs was well 
enough to induce 50% cell mortality as compared to other ZnO, 
Zn0.95Ce0.05O, and Zn0.85Ce0.15O NPs. The Zn0.90Ce0.10O NPs showed a 
highly effective cytotoxic activity against (A549) human lung cancer 
cell. The cytotoxic efficiency of the ZnO NPs generally depends on 
the presence of ROS.
AO and EB staining
The most important characteristics of apoptosis are morphological 
changes during cell death. Fig. 6 represents that AO/EB double-stained 
A549 human lung cancer cell line treated with test substances 24 hr 
underwent both early apoptosis and late apoptosis. The control or 
viable cells show green fluorescence and normal cell features of 
uniform chromatin with an intact cell membrane, whereas the early 
apoptosis cells showed bright green region with yellowish green 
nuclear fragmentation and membrane bubbles and apoptotic bodies 
outside. The late apoptosis cells exhibited orange-yellow or red nuclei 
with condensed or fragmented chromatin. The results demonstrate 
that all substances induce the majority of cell death through apoptosis 
mode and very fewer in necrosis for 24 hr treatment. Chromatin 
condensation and fragmentation were observed in ZnO and Zn1-xCexO 
(x=0.05, 0.10, and 0.15) NPs treated cells.
The cellular toxicity mechanisms are based on ROS production, 
which exceeds the capacity of cellular antioxidant defense system 
causes cells to enter the state of oxidative stress. These oxidative 
stresses damage the cellular components such as lipids, proteins, 
and DNA [19,20]. The oxidation of fatty acids leads to the generation 
of lipid peroxides that initiates a chain reaction leading to disruption 
of plasma, organelle membranes, and subsequent cell death 
by induction of apoptosis. The ROS act as the critical signaling 
mechanism in the induction of apoptosis/cell death by many 
different stimuli [21,22].
CONCLUSIONS
Thus ZnO and Ce-doped ZnO NPs were prepared by co-precipitation 
method. From the XRD pattern, ZnO and Ce-doped ZnO NPs were 
revealed as wurtzite structure. The average crystallite sizes were 
calculated as 39, 32, 30, and 27 nm for ZnO and Ce-doped ZnO NPs, 
respectively. HRSEM image showed the spherical shape of ZnO and Ce-
doped ZnO NPs. From antibacterial result, Zn0.85Ce0.15O NPs possessed 
more antibacterial effect as compared to the other ZnO and Zn1-xCexO 
(x=0.05 and 0.10) NPs. The cytotoxic effect of the ZnO and Zn1-xCexO 
(x=0.05, 0.10, and 0.15) NPs were examined in cultured (A549) human 
lung cancer cell line, in which the Zn0.90Ce0.10O NPs showed the highest 
cytotoxic activity. With reference to cell death, a minimum concentration 
of 68±0.05 μg/ml of the Zn0.90Ce0.10O NPs was well enough to induce 
50% cell mortality as compared to ZnO and Zn1-xCexO (x=0.05 and 0.15) 
NPs, respectively.
Fig. 3: The antibacterial activity of the zinc oxide aND Zn1-xCexO (x=0.05, 0.10, and 0.15) against Gram-positive (Streptococcus aureus 
(2) and Streptococcus pneumonia (6)) and Gram-negative (Escherichia coli (4), Pseudomonas aeruginosa (5), Proteus vulgaris 
(7), Klebsiella pneumonia (1), and Shigella dysenteriae (3))
Fig. 4: The size of the zone inhibition surrounding each disc, 
filled with test samples specifies the activity as antibacteria 
toward Gram-positive (Streptococcus aureus and Streptococcus 
pneumonia) and Gram-negative (Escherichia coli, Pseudomonas 
aeruginosa, Proteus vulgaris, Klebsiella pneumonia, and Shigella 
dysenteriae) for the zinc oxide and Zn1-xCexO (x=0.05, 0.10, 
and 0.15) nanoparticles
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